1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Ay C, Dunkler D, Pirker R, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica, 2012, 97(8): 1158-1164.
|
3. |
Park K, Ryoo BY, Ryu MH, et al. Incidence of venous throm-boembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study. World J Gastrointest Oncol, 2017, 9(4): 176-183.
|
4. |
高军, 李富良, 何旭. Ⅱ/Ⅲ型胃食管结合部腺癌淋巴结转移的影响因素及其对预后的影响. 中国普外基础与临床杂志, 2018, 25(11): 1327-1331.
|
5. |
周魁平, 丁祥飞, 吴云阳, 等. 早期胃癌淋巴结转移与临床病理特征相关危险因素分析. 基因组学与应用生物学, 2018, 37(2): 618-623.
|
6. |
张波, 令狐恩强, 柴宁莉, 等. 内镜黏膜下剥离术治疗早期胃癌中脉管癌栓相关因素分析. 临床军医杂志, 2018, 46(1): 34-36, 40.
|
7. |
Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol, 2013, 19(9): 1424-1437.
|
8. |
朱信强, 张明, 丁闯, 等. 不同病理类型进展期胃癌的预后因素分析. 中国普外基础与临床杂志, 2017, 24(5): 580-586.
|
9. |
Li P, He HQ, Zhu CM, et al. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer, 2015, 15: 370.
|
10. |
Matsumoto T, Kubota K, Aoki T, et al. Clinical impact of anatomical liver resection for hepatocellular carcinoma with pathologically proven portal vein invasion. World J Surg, 2016, 40(2): 402-411.
|
11. |
Wang WL, Ye S, Yan S, et al. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int, 2015, 14(4): 429-435.
|
12. |
程树群, 孙居仙. 肝癌合并门静脉癌栓的诊治进展. 中国普外基础与临床杂志, 2019, 26(5): 513-518.
|
13. |
Luo J, Yan Z, Liu Q, et al. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein. J Vasc Interv Radiol, 2011, 22(4): 479-489.
|
14. |
Chen LW, Chien RN, Fang KM, et al. Elucidating therapeutic effects on patients with hepatocellular carcinoma and main portal vein thrombosis. Hepatogastroenterology, 2010, 57(98): 228-231.
|
15. |
周俭, 肖永胜, 樊嘉. 肝癌合并门静脉癌栓的研究进展. 中国普外基础与临床杂志, 2012, 19(3): 243-246.
|
16. |
Zhang QW, Zhang XT, Gao YJ, et al. Endoscopic management of patients with early gastric cancer before and after endoscopic resection: A review. J Dig Dis, 2019, 20(5): 223-228.
|
17. |
Virgilio E, Balducci G, Mercantini P, et al. Laparoscopic intragastric surgery for treating early gastric cancer. Anticancer Res, 2018, 38(4): 1911-1916.
|
18. |
Pyo JH, Lee H, Min BH, et al. Comparison of long-term outcomes after non-curative endoscopic resection in older patients with early gastric cancer. Ann Surg Oncol, 2017, 24(9): 2624-2631.
|
19. |
Vogel SM, Smith LV, Peterson EJ. First-line therapies for vte treatment and secondary prophylaxis in patients with cancer: a new direction. J Pharm Pract, 2018 Dec 12: 897190018775580. doi: 10.1177/0897190018775580.
|
20. |
López-Núñez JJ, Trujillo-Santos J, Monreal M. Management of venous thromboembolism in patients with cancer. J Thromb Haemost, 2018, 16(12): 2391-2396.
|
21. |
Diao D, Cheng Y, Song Y, et al. D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer, 2017, 17(1): 56.
|
22. |
Diao D, Wang Z, Cheng Y, et al. D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients. PLoS One, 2014, 9(7): e101125.
|
23. |
马丽华, 钱屹崟, 吴剑平, 等. D-二聚体和肿瘤标记物在胃癌诊断中的价值. 江苏医药, 2014, 40(17): 2019-2021.
|
24. |
杜彬, 陈强. 血浆D-二聚体水平与转移性胃癌临床特征及生存期相关分析. 福建医科大学, 2015: 52.
|
25. |
Hakoum MB, Kahale LA, Tsolakian IG, et al. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer. Cochrane Database Syst Rev, 2018, 1: CD006649.
|
26. |
Kuderer NM, Khorana AA, Lyman GH, et al. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer, 2007, 110(5): 1149-1161.
|
27. |
Yu J, Li D, Lei D, et al. Tumor-specific D-dimer concentration ranges and influencing factors: a cross-sectional study. PLoS One, 2016, 11(11): e0165390.
|